Oral vitamin D3 raises prostate calcitriol levels (level 1 evidence) and modestly lowers both PSA and PTH, justifying continued clinical research. Dennis Wagner, Dominique Trudel, Theodorus Van der Kwast, Larisa Nonn, Angeline Antonio Giangreco, Doris Li, Andre Dias, Monique Cardoza, Sanda Laszlo, Karen Hersey, Laurence Klotz, Antonio Finelli, Neil Fleshner, and Reinhold Vieth. Randomized Clinical Trial of Vitamin D3 Doses on Prostatic Vitamin D Metabolite Levels and Ki67 Labeling in Prostate Cancer Patients.
ARF has novel function in modulation of AR transactivation in PCa. Wenfu Lu, Yingqiu Xie, Yufang Ma, Robert J. Matusik, and Zhenbang Chen. ARF Represses Androgen Receptor Transactivation in Prostate Cancer.
Cancer-Oncogenes: FRα plays a critical role in mediating the antitumor effect of F-L-DOX. Xiaohai Liu, Sihai Ma, Congxin Dai, Feng Cai, Yong Yao, Yakun Yang, Ming Feng, Kan Deng, Guiling Li, Wenbing Ma, Bing Xin, Wei Lian, Guangya Xiang, Bo Zhang, and Renzhi Wang. Antiproliferative, Antiinvasive, and Proapoptotic Activity of Folate Receptor α-Targeted Liposomal Doxorubicin in Nonfunctional Pituitary Adenoma Cells.
Franck MauvaisJarvis, Deborah J. Clegg, and Andrea L. Hevener. The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis.